Skip to content
Independent analysis of NHS open data
PharmaInsight

Secukinumab vs Methotrexate

National NHS prescribing compared (Prescription Cost Analysis)
Data updated April 2026

Methotrexate was dispensed 182,888.0× as often as Secukinumab in April 2026 — 182,888 items versus 1 in England.

1items

Secukinumab · April 2026

NHSBSA Prescription Cost Analysis

182,888items

Methotrexate · April 2026

NHSBSA Prescription Cost Analysis

Figure 1. Secukinumab versus Methotrexate: national items dispensed by month

▬ Secukinumab   ·   ╌ Methotrexate

0 99k 198k Aug 2021 Dec 2021 Apr 2022 May 2023 Mar 2024 Apr 2025 Apr 2026 Methotrexate 1 Aug 2021: 7 Sep 2021: 7 Oct 2021: 7 Nov 2021: 11 Dec 2021: 7 Jan 2022: 11 Feb 2022: 4 Mar 2022: 10 Apr 2022: 3 May 2022: 6 Jun 2022: 3 Mar 2023: 3 May 2023: 1 Aug 2023: 3 Sep 2023: 1 Jan 2024: 1 Mar 2024: 1 Apr 2024: 1 May 2024: 3 Jul 2024: 1 Apr 2025: 1 Sep 2025: 1 Nov 2025: 1 Feb 2026: 1 Apr 2026: 1

Source: NHSBSA Prescription Cost Analysis, to April 2026

Secukinumab versus Methotrexate, April 2026
Measure Secukinumab Methotrexate
Items, April 2026 1 182,888
Items, last 12 months 16 2,236,227
Net ingredient cost, April 2026 £609 £2,247,752

See the full profile for Secukinumab or Methotrexate.